Emerson Electric vs General Electric
EMR and GE side by side, both in electronic and other electrical equipment and components, except computer equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EMR and GE compare
General Electric is the larger company, worth 3.5 times as much as Emerson Electric ($325B against $92.0B).
On earnings, Emerson Electric is cheaper: it trades at 36.1× trailing earnings, against 36.9× for General Electric.
General Electric grew revenue faster over the last twelve months (21.7% versus 4.8% for Emerson Electric).
General Electric keeps more of each dollar of sales as profit, with a net margin of 17.7% compared with 13.8% at Emerson Electric.
Both pay dividends: Emerson Electric yields 1.3% and General Electric 0.57%.
General Electric scores higher on the StockData Score (14 against 11 for Emerson Electric), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EMR | GE |
|---|---|---|
| Size and price | ||
| Market cap | $92.0B | $325B |
| Share price | $164.94 | $313.05 |
| Change, 1 year | 20.9% | 1.1% |
| Change, 5 years | 68.4% | 188% |
| Beta (5Y) | 1.10 | 1.18 |
| Employees | 71K | 57K |
| StockData Score | ||
| Total score | 11 | 14 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 1 | 4 (better) |
| Performance score | 3 | 5 (better) |
| Health score | 3 | 3 |
| Dividend score | 4 (better) | 1 |
| Valuation | ||
| P/E | 36.1× (better) | 36.9× |
| P/S | 4.9× (better) | 6.4× |
| P/B | 4.5× (better) | 18.4× |
| EV/EBITDA | 21.6× (better) | 29.8× |
| P/FCF | 26.6× (better) | 38.7× |
| PEG | – | 0.08 |
| FCF yield | 3.8% (better) | 2.6% |
| Fair value | $142.44 | $286.64 |
| Margin of safety | −15.8% | −9.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 4.8% | 21.7% (better) |
| Revenue growth, 5Y average | 1.4% (better) | −9.6% |
| Net income growth (TTM) | −2.8% | 15.7% (better) |
| EPS growth (TTM) | −1.7% | 18.4% (better) |
| EPS growth, 5Y average | 4.5% | 11.9% (better) |
| Profitability | ||
| Gross margin | 53.2% | – |
| Net margin | 13.8% | 17.7% (better) |
| FCF margin | 18.6% (better) | 16.6% |
| Return on equity | 12.8% | 48.8% (better) |
| Financial health | ||
| Debt / equity | 0.64 (better) | 1.09 |
| Net debt / EBITDA | 2.29 | 0.87 (better) |
| Current ratio | 0.90 | 0.98 (better) |
| Altman Z-score | 4.32 (better) | 3.16 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.3% (better) | 0.57% |
| Payout ratio | 47.8% | – |
| Years of dividend growth | 16 (better) | 2 |
| Dividend growth, 5Y average | 1.1% | 35.1% (better) |
| Buyback yield | 1.00% | 2.6% (better) |
| Shareholder yield | 2.3% | 3.1% (better) |
| Ownership | ||
| Held by institutions | 82.5% | 79.6% |
| Held by insiders | 0.30% | 0.57% |
| Insider net buying, 12 months | −$7.9M (better) | −$21.3M |
| Superinvestors holding | 1 | 5 (better) |
| Short interest, % of float | 1.6% | 1.1% |
Go deeper
- EMR stock overview
- EMR income statement
- EMR valuation and score
- GE stock overview
- GE income statement
- GE valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.